Skip to main content

Advertisement

Log in

B cell activation in patients with rheumatic disease: association with an increased ratio of Th2: Th1 cytokine secreting cells

  • Review
  • Published:
Japanese Journal of Rheumatology

Abstract

This minireview examines the pattern of Th1 and Th2 cytokine-secreting cells present in the peripheral blood of patients with rheumatic diseases including lupus, myositis, Sjögren’s syndrome and rheumatoid arthritis. The general conclusion is reached that diseases marked by increased B cell activation are characterized by a relative increase in the frequency of peripheral blood mononuclear cells secreting Th2 versus Th1 cytokines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mosmann TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties.Annu Rev Immunol 7: 147–171, 1989.

    Article  Google Scholar 

  2. Mosmann TR, Cherwinski H, Bond MWet al.: Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins.J Immunol 136: 2348–2357, 1986.

    CAS  PubMed  Google Scholar 

  3. Moore KW, Vieira P, Fiorentino DRet al.: Homology of cytokine synthesis inhibitory factor (IL-10) to the EBV gene BCRF1.Science 248: 1230–1234, 1990.

    Article  CAS  PubMed  Google Scholar 

  4. Tanaka T, Hu-Li J, Seder RAet al.: IL-4 suppresses IL-2 and IFN-γ production by naive T cells stimulated by accessory cell-dependent receptor engagement.Proc Natl Acad Sci USA 90: 5914–5918, 1993.

    Article  CAS  PubMed  Google Scholar 

  5. Seder RA, Paul WE, Mark MDet al.: The presence of IL-4 during in vitro proming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.J Exp Med 176: 1091–1098, 1992.

    Article  CAS  PubMed  Google Scholar 

  6. Parronchi P, DeCarli M, Manetti Ret al.: IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones.J Immunol 149: 2977–2983, 1992.

    CAS  PubMed  Google Scholar 

  7. Shirai A, Conover J, Klinman DM: Increased activation and altered ratio of IFNg: IL-4 secreting cells in MRL/lpr mice.Autoimmunity 21: 107–116, 1996.

    Article  Google Scholar 

  8. Takahashi S, Fossati L, Owamoto Met al.: Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.J Clin Invest 97: 1597–1604, 1996.

    Article  CAS  PubMed  Google Scholar 

  9. Steinberg AD, Klinman DM: Pathogenesis of systemic lupus erythematosus.Rheum Dis Clin N Am 14: 25–41, 1988.

    CAS  Google Scholar 

  10. Klinman DM, Steinberg AD: Systemic autoimmune disease arises from polyclonal B cell activation.J Exp Med 165: 1755–1760, 1987.

    Article  CAS  PubMed  Google Scholar 

  11. Klinman DM, Eisenberg RA, Steinberg AD: Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice.J Immunol 1440: 506–512, 1990.

    Google Scholar 

  12. Linker-Israeli M, Deans R, Wallace Det al.: Elevated levels of endogenous IL-6 in systemic lupus erythematosus.J Immunol 147: 117–123, 1991.

    CAS  PubMed  Google Scholar 

  13. Kitani A, Hara M, Hirose Tet al.: Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression.Clin Exp Immunol 88: 75–83, 1992.

    Article  CAS  PubMed  Google Scholar 

  14. Nagafuchi H, Suzuki N, Mizushima Yet al.: Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.J Immunol 151: 6525–6534, 1993.

    CAS  PubMed  Google Scholar 

  15. Kitani A, Hara M, Hirose Tet al.: Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythematosus.Clin Exp Immunol 77: 31–36, 1989.

    CAS  PubMed  Google Scholar 

  16. Spronk P, Ter Borg E, Limburg Pet al.: Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?Clin Exp Immunol 90: 106–110 1992.

    CAS  PubMed  Google Scholar 

  17. Al-Janadi M, Al-Balla S, Al-Dalaan Aet al.: Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases.J Clin Immunol 13: 58–67, 1993.

    Article  CAS  PubMed  Google Scholar 

  18. Hagiwara E, Gourley M, Lee Set al.: Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of IL-10: IFNgamma secreting cells in the peripheral blood.Arthritis Rheum 39: 379–385, 1996.

    Article  CAS  PubMed  Google Scholar 

  19. Briere F, Servet-Delprat C, Bridon Jet al.: Human interleukin-10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3.J Exp Med 179: 757–762, 1994.

    Article  CAS  PubMed  Google Scholar 

  20. Llorente L, Zou W, Levy Yet al.: Role of IL-10 in the B lymphocyte hyperactivity and autoantibody production of human SLE.J Exp Med 181: 839–844, 1995.

    Article  CAS  PubMed  Google Scholar 

  21. Llorente L, Richaud-Patin Y, Wijdenes Jet al.: Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus.Eur Cytokine Netw 4: 421–430, 1993.

    CAS  PubMed  Google Scholar 

  22. Houssiau FA, Lefebvre C, Vanden Berghe Met al.: Serum IL-10 titers in SLE reflect disease activy.Lupus 4: 393–395, 1995.

    Article  CAS  PubMed  Google Scholar 

  23. Richaud-Patin R, Alcocer-Varela J, Llorente L: High levels of Th2 cytokine gene expression in SLE.Rev Invest Clin 47: 267–272, 1995.

    CAS  PubMed  Google Scholar 

  24. Kroemer G, Martinez-a C: Short Analytical review: cytokines and autoimmune disease.Clin Immunol Immunopathol 61: 275–295, 1991.

    Article  CAS  PubMed  Google Scholar 

  25. Goldman M: Review: cytokines in the pathogenesis of systemic lupus erythematosus.Autoimmunity 8: 173–179, 1990.

    Article  CAS  PubMed  Google Scholar 

  26. Horwitz DA, Wang H, Gray JD: Cytokine gene profiles in circulating blood mononuclear cells from patients with SLE: Increased IL-2 but not IL-4 mRNA.Lupus 3: 423–428, 1994.

    Article  CAS  PubMed  Google Scholar 

  27. Huang YP, Perrin LH, Miescher PAet al.: Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.J Immunol 141: 827–833, 1988.

    CAS  PubMed  Google Scholar 

  28. Hagiwara E, Abbasi F, Mor Get al.: Phenotype and frequency of cells secreting IL-2, IL-4, IL-6 IL-10, IFNg and TNFa in human peripheral blood.Cytokine 7: 815–822, 1995.

    Article  CAS  PubMed  Google Scholar 

  29. Hagiwara E, Adams EM, Plotz PHet al.: Abnormal cytokine production by peripheral blood mononuclear cells from patients with polympositis and dermatomyositis.Clin Exp Rheum 14: 485–491, 1996.

    CAS  Google Scholar 

  30. Feldman M, Brennan FM, Chantry Det al.: Cytokine assays: role in evaluation of the pathogenesis of autoimmunity.Immunol Rev 119: 105–123, 1991.

    Article  Google Scholar 

  31. Firestein GS, Alvaro-Gracia J, Maki R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis.J Immunol 144: 3347, 1990.

    CAS  PubMed  Google Scholar 

  32. Miyasaka N, Sato K, Goto M: Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: possible involvement in joint destruction.Arthritis Rheum 31: 480, 1988.

    Article  CAS  PubMed  Google Scholar 

  33. Fong K, Boey M, Koh Wet al.: Cytokine concentration in the synovial fluid and plasma of rheumatoid arthritis patients: correlation with bony erosions.Clin Exp Rheum 12: 55–58, 1994.

    CAS  Google Scholar 

  34. Hirano T, Matsuda T, Turner Met al.: Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis.Eur J Immunol 18: 1797–1801, 1988.

    Article  CAS  PubMed  Google Scholar 

  35. Schulze-Koops H, Lipsky PE, Kavanaugh AFet al.: Elevated Th1 or Th0-like cytokine mRNA in periphal circulation of patients with rheumatoid arthritis.J Immunol 155: 5029–5037, 1995.

    CAS  PubMed  Google Scholar 

  36. Quayle AJ, Chomarat P, Miossex Pet al.: Rheumatoid inflammatory T cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns.Scand J Immunol 38: 75–82, 1993.

    Article  CAS  PubMed  Google Scholar 

  37. Wolf RE, Baethge BA: IL-1, IL-2 and soluble IL-2R in polymyositis.Arthritis Rheum 33: 1007–1014, 1990.

    Article  CAS  PubMed  Google Scholar 

  38. Mantegazza R, Bernasconi P: Cellular aspects of myositis.Curr Opin Rheum 6: 568–574, 1994.

    Article  CAS  Google Scholar 

  39. Villarreal GM, Alcocer-Varela J, Llorente L: Cytokine gene and CD25 antigen expression in peripheral blood T cells from patients with primary Sjögren’s syndrome.Autoimmunity 20: 223–229, 1995.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Hagiwara, E., Ishigatsubo, Y. & Klinman, D.M. B cell activation in patients with rheumatic disease: association with an increased ratio of Th2: Th1 cytokine secreting cells. Japanese Journal of Rheumatology 7, 145–152 (1997). https://doi.org/10.1007/BF03041236

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03041236

Key words

Navigation